Enzymatic Labeling of Bacterial Proteins for Super-resolution Imaging in Live Cells by Ho, Samuel H. & Tirrell, David A.
Supporting Information  Ho and Tirrell 
Supporting Information 
 
Enzymatic Labeling of Bacterial Proteins for Super-Resolution Imaging in Live Cells 
Samuel H. Ho and David A. Tirrell* 
 
Division of Chemistry and Chemical Engineering, California Institute of Technology 
Pasadena, California 91125, United States 
 
tirrell@caltech.edu 
 
Table of Contents 
 
Materials and Methods ................................................................................................................................. 1 
Schemes S1–S3: Synthesis of compounds ................................................................................................. 2 
Synthesis and characterization of compounds ......................................................................................... 3–7 
Figure S1: Absorption spectra of rhodamine 4 in bis-tris propane at different pH values ............................ 8 
Figure S2: Fluorescence emission from rhodamine 4 in bis-tris propane at different pH values ................. 9 
Figure S3: Absorption spectra of rhodamine 5 in bis-tris propane at different pH values .......................... 10 
Figure S4: Fluorescence emission from rhodamine 5 in bis-tris propane at different pH values ............... 11 
Figure S5: Spectroscopic characterization of rhodamine 4 in different solvents ........................................ 12 
Figure S6: Spectroscopic characterization of rhodamine 5 in different solvents ........................................ 13 
Figure S7: Spectroscopic characterization of rhodamines 4 and 5 in solvents of different dielectric constants 
.................................................................................................................................................................... 14 
Figure S8: Radial and axial resolutions for E. coli cells expressing Tar and labeled with 2 ....................... 15 
Figure S9: Super-resolution imaging of bacterial proteins in live cells labeled with 3 ................................ 16 
Figure S10: Radial and axial resolutions for E. coli cells expressing Tar and labeled with 3 ..................... 17 
Figure S11: Control imaging experiments with live cells labeled with 2 ..................................................... 18 
Figure S12: Control imaging experiments with live cells labeled with 3 ..................................................... 19 
Figure S13: Addition of dyes 2 or 3 does not affect cell growth  ................................................................ 20 
Figure S14: Growth effects of protein expression, the N-terminal NMT recognition sequence, and 
modification with fatty acid. ........................................................................................................................ 21 
Figures S15–S36: NMR spectra ........................................................................................................... 22–34 
Figure S37: LC-MS trace of 2 ..................................................................................................................... 35 
Figure S38: High-resolution mass spectrum of 2 ....................................................................................... 35 
Figure S39: LC-MS trace of 3 ..................................................................................................................... 36 
Figure S40: High-resolution mass spectrum of 3 ....................................................................................... 36 
  
Supporting Information  Ho and Tirrell 
 – 1 – 
Materials and Methods 
 
(A) Synthetic procedures: Unless otherwise stated, all synthetic reactions were performed using oven-
dried glassware and PTFE stir bars under an atmosphere of argon. Anhydrous solvents were purchased 
from Sigma-Aldrich and kept under argon. Other chemicals and reagents for chemical reactions were 
purchased from Sigma Aldrich and used without further purification. Reactions were monitored with thin 
layer chromatography (EMD/Merck silica gel 60 F254 pre-coated plates) and UV light for visualization. 
Flash chromatography purifications were carried out using a Biotage Isolera One purification system with 
pre-packed SNAP Ultra (silica) or SNAP KP-NH (amine-functionalized silica) columns. The gradient of the 
eluent is given as a percentage of strong solvent per column volume (CV). 1H and 13C NMR spectra were 
measured on a Bruker Prodigy 400 spectrometer (at 400 MHz and 101 MHz, respectively) equipped with a 
cryogenic probe.  19F NMR spectra were recorded on either a Varian 300 (282 MHz) or a Bruker 400 (376 
MHz) instrument. 1H, 13C, and 19F chemical shifts are reported as δ in units of parts per million (ppm) 
relative to tetramethylsilane (TMS, δ = 0) and calibrated using the residual solvent peak in chloroform (δ 
7.26, singlet for 1H; δ 77.16 for 13C; and δ 0 for 19F, respectively) or dimethylsulfoxide (δ 2.50, quintet for 
1H; δ 39.52 for 13C; and δ 0 for 19F, respectively). Data for 1H NMR are reported as follows: chemical shift 
(δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = multiplet, br = broad, 
dd= doublet of doublets, td = triplet of doublets, dt = doublet of triplets), coupling constant (Hz), and 
integration. High-resolution mass spectrometry (HRMS) was performed with either a JEOL JMS-600H High 
Resolution Mass Spectrometer with fast atom bombardment (FAB) or an LCT Premier XE Electrospray 
TOF Mass Spectrometer with electrospray ionization (ESI) at the California Institute of Technology Mass 
Spectrometry Facility in the Division of Chemistry and Chemical Engineering. HMRS data are reported as 
follows: calculated mass, observed mass, error in ppm. Liquid chromatography (LC) coupled with low-
resolution mass spectrometry (LRMS) was performed using an Agilent 1290 UHPLC–MS in positive mode 
at the Center for Catalysis and Chemical Synthesis in the Caltech Beckman Institute. 
(B) Molecular biology: Lysogeny broth (LB) contained 10 g casein hydrolysate, 5 g yeast extract, and 10 
g NaCl per liter of double-distilled water (ddH2O). Ampicillin sodium salt (BioPioneer, USA) and kanamycin 
sulfate (BioPioneer, USA) were used at working concentrations of 200 µg/mL and 35 µg/mL, respectively. 
Phosphate-buffered saline (PBS) was purchased as a 10X stock solution from Thermo Fisher Scientific 
(USA) and diluted to 1X (pH 7.4) in ddH2O as needed. Colonies were grown on LB agar plates carrying the 
appropriate antibiotic supplements. Plates containing colonies were always used within one week or 
discarded. 
(C) Construction of strains without NMT recognition sequence. Primers were used to amplify Tar or 
FtsA without the NMT recognition sequence, using the modified pBAD24 plasmids bearing sequences for 
bacterial proteins with the NMT recognition sequence as described in [1]. For Tar, the primers were 5’-
ATATATGAATTCACCATGATTAACCGTATCCGCGTAGTCAC-3’ and 5’- ATATATAAGCTTCTACAGAT 
CTTCTTCAGAAATAAGTTTTTGTTC-3’. For construction of FtsA without the recognition sequence, the 
primers used for amplification were 5’- ATATATGAATTCACCATGATCAAGGCGACGGACAGAAAAC’-3’ 
and 5’-GATCTTCTTCAGAAATAAGTTTTTGTTCGAGCTC’-3’. PCR products were digested with 
EcoRI/HindIII (for Tar) and EcoRI/SacI (for FtsA) and ligated into the pBAD24 vector using standard 
restriction enzyme digestion and ligation methods. Plasmids were transformed into E. coli strain BL21 
harboring the pHV738-NMT-MetAP plasmids to generate strains SHH013 and SHH014 (Figure S14). 
Colonies were selected against ampicillin (200 µg/mL) and kanamycin (35 µg/mL). 
(D) Cell viability with fluorophores 2 and 3. Individual colonies (strain SHH009) were used to inoculate 
LB medium supplemented with 200 µg/mL ampicillin and 35 µg/mL kanamycin, and cultures were grown 
overnight at 37 °C with mild agitation (250 rpm). Cultures were diluted to an OD600 of 0.01 in LB medium 
(also supplemented with 200 µg/mL ampicillin and 35 µg/mL kanamycin). To each culture was added 200 
nM fluorophore 2 or 3. Cultures were allowed to continue to grow in the presence of each compound, and 
OD600 was monitored every 10 min for 14 h using a Varioskan LUX microplate reader (Thermo Fisher, 
USA). The OD600 of cultures grown without the presence of 2 or 3 were also measured as a control. 
 
[1] Ho, S. H.; Tirrell, D. A. J. Am. Chem. Soc. 2016, 138, 115098–15101. 
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Synthesis of compounds 
 
 
Scheme S1: Synthesis of rhodamines S1 and 4. 
 
 
 
Scheme S2: Synthesis of rhodamines S2 and 5.  
 
 
 
Scheme S3: Synthesis of rhodamine spirolactams 2 and 3.
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Synthesis and characterization of compounds 
 
Rhodamine intermediate (S1): To a flame-dried 100 mL round bottom 
flask, was added Rhodamine B (1.5 g, 3.13 mmol, 1.0 eq), PTFE stir 
bar, and 20 mL acetonitrile at room temperature. Phosphorus(V) 
oxychloride (0.875 mL, 9.39 mmol, 3.0 eq) was added all at once to the 
reaction mixture, and the flask was quickly attached to a reflux 
condenser (14/20 neck size). The solution was heated to 92 °C and 
allowed to reflux for 4 h, after which the solution was cooled to room temperature and 
concentrated in vacuo to give a purple solid bearing the acid chloride. In a separate 100 mL round 
bottom flask, 4-aminopyridine (884.1 mg, 9.39 mmol, 3.0 eq) was dissolved in 30 mL acetonitrile. 
Triethylamine (1.309 mL, 9.39 mmol, 3.0 eq) was added to the solution containing 4-
aminopyridine. This pre-mixed solution was then added to the acid chloride via syringe (5 mL per 
min over the course of 6 min) at room temperature. Gas evolution occurred upon addition of the 
solution to the acid chloride. The solution was allowed to stir at room temperature for 14 h, after 
which the solution was concentrated in vacuo. Ethyl acetate (50 mL) was added to the resultant 
solid, and the mixture was transferred to a 1 L separatory funnel. Saturated NaHCO3 (30 mL) was 
added to wash the organic layer. The organic layer was collected and washed two more times 
with saturated NaHCO3 (2 x 30 mL). The organic layer was washed three times with saturated 
NaCl (3 x 50 mL), dried over MgSO4, and concentrated in vacuo, resulting in a purple and white 
solid. Flash chromatography (Biotage SNAP KP-NH, 6–60% ethyl acetate/hexanes over 15 CVs) 
afforded 1.28 g (78.7%) of S1 as white solid. 1H NMR (400 MHz, chloroform-d) δ 8.35 – 8.30 (m, 
2H), 8.00 – 7.95 (m, 1H), 7.51 – 7.42 (m, 2H), 7.39 – 7.36 (m, 2H), 7.09 – 7.06 (m, 1H), 6.55 (d, 
J = 8.9 Hz, 2H), 6.37 (d, J = 2.5 Hz, 2H), 6.23 (dd, J = 8.9, 2.6 Hz, 2H), 3.31 (q, J = 7.1 Hz, 8H), 
1.15 (t, J = 7.0 Hz, 12H). 13C NMR (101 MHz, chloroform-d) δ 168.96, 154.37, 152.50, 150.05, 
149.05, 145.18, 134.00, 128.56, 128.37, 128.05, 123.85, 123.68, 116.92, 108.42, 106.06, 98.01, 
66.95, 44.45, 12.73. HRMS (FAB) calculated for C33H35O2N4 ([M+H]+) 519.2760, found 519.2761 
(∆ = 0.2 ppm). 
 
Rhodamine spirolactam (4): To a flame-dried 2-neck (14/20) 25 mL 
round bottom flask, was added rhodamine S1 (200 mg, 0.386 mmol, 
1.0 eq), PTFE stir bar, and 10 mL acetonitrile. Methyl iodide (48 µL, 
0.771 mmol, 2.0 eq) was quickly added to the solution all at once 
and the flask was attached to a reflux condenser. The solution was 
allowed to reflux at 92 °C for 4 h. TLC was performed to monitor the 
reaction progress using a solvent system of 2% v/v methanol in methylene chloride. TLC showed 
that the starting material had not all been consumed. Additional methyl iodide (24 µL, 0.386 mmol, 
1.0 eq) was added to the refluxing solution, and the reaction continued to reflux for an additional 
2 h. TLC (2% v/v methanol in methylene chloride) indicated the presence of starting material, so 
additional methyl iodide (12 µL, 0.193 mmol, 0.5 eq) was added to the reaction mixture. The 
reaction mixture was allowed to reflux for an additional 1 h, after which TLC indicated complete 
consumption of starting material (total 6 h of reflux with total 3.5 eq of electrophile). Solvent from 
the reaction mixture was removed in vacuo and the resultant brown oil was dissolved in a minimal 
amount of methylene chloride (2 mL). A mixture of hexanes was added to triturate 4 as a solid. 
The solid was collected by filtration, washed with hexanes (3 x 5 mL), and dried under vacuum to 
afford 154.5 mg (60.6%) of rhodamine spirolactam 4 (iodide salt) as a tan solid. 1H NMR (400 
MHz, DMSO-d6) δ 8.68 – 8.64 (m, 2H), 8.08 – 8.04 (m, 2H), 8.01 (dt, J = 7.5, 1.0 Hz, 1H), 7.67 
(td, J = 7.5, 1.2 Hz, 1H), 7.59 (td, J = 7.5, 1.0 Hz, 1H), 7.06 (dt, J = 7.7, 0.8 Hz, 1H), 6.57 (d, J = 
8.9 Hz, 2H), 6.47 (d, J = 2.7 Hz, 2H), 6.30 (dd, J = 9.0, 2.6 Hz, 2H), 4.04 (s, 3H), 3.30 (m, 8H), 
NN
ON N
O
CH3N
N
ON N
O I
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1.07 (t, J = 6.9 Hz, 12H). 13C NMR (101 MHz, DMSO-d6) δ 169.11, 154.01, 151.58, 149.34, 148.89, 
145.63, 136.00, 129.23, 127.28, 125.53, 124.05, 123.67, 114.70, 108.58, 104.03, 97.43, 66.74, 
46.44, 43.63, 12.39. HRMS (FAB) calculated for C34H37O2N4 ([M]+) 533.2916, found 533.2929 (∆ 
= 2.4 ppm). 
 
Rhodamine intermediate (S2): To a flame-dried 100 mL round bottom 
flask was added Rhodamine B, (1.5 g, 3.13 mmol, 1.0 eq), PTFE stir bar, 
and 10 mL acetonitrile. Phosphorus(V) oxychloride (0.875 mL, 9.39 mmol, 
3.0 eq) was added all at once to the reaction mixture and the flask was 
quickly attached to a reflux condenser (14/20 neck size). The solution 
was heated to 92 °C and allowed to reflux for 4 h, after which the solution 
was cooled to room temperature and concentrated in vacuo to give a purple solid bearing the acid 
chloride. In a separate 100 mL round bottom flask, 4-amino-3-fluoropyridine (1.053 g, 9.39 mmol, 
3.0 eq) was dissolved in 30 mL acetonitrile and triethylamine (1.309 mL, 9.39 mmol, 3.0 eq) was 
added. The resulting solution was added to the acid chloride (5 mL per min over the course of 6 
min) at room temperature. Gas evolution occurred upon addition of the solution containing 4-
amino-3-fluoropyridine to the acid chloride. The solution was allowed to stir at room temperature 
for 16 h, after which the solution was concentrated in vacuo. Ethyl acetate (50 mL) was added to 
the resultant solid, and the mixture was transferred to a 1 L separatory funnel. Saturated NaHCO3 
(30 mL) was added to wash the organic layer. The organic layer was collected and washed two 
more times with saturated NaHCO3 (2 x 30 mL). The organic layer was washed three times with 
saturated NaCl (3 x 30 mL), dried over MgSO4, and concentrated in vacuo, resulting in a purple 
and white solid. Flash chromatography (Biotage SNAP KP-NH, 6–60% ethyl acetate/hexanes 
over 15 CVs) afforded 1.04 g (62%) of S2 as white solid. 1H NMR (400 MHz, chloroform-d) δ 8.35 
(d, J = 2.2 Hz, 1H), 8.10 (d, J = 5.2 Hz, 1H), 8.05 – 7.99 (m, 1H), 7.56 – 7.47 (m, 2H), 7.17 – 7.11 
(m, 1H), 6.67 (d, J = 8.8 Hz, 2H), 6.39 – 6.35 (m, 1H), 6.31 (dd, J = 8.9, 2.7 Hz, 2H), 6.27 (d, J = 
2.6 Hz, 2H), 3.32 (q, J = 7.1 Hz, 8H), 1.15 (t, J = 7.1 Hz, 12H). 13C NMR (101 MHz, chloroform-d) 
δ 166.77, 156.59, 154.10, 153.98, 153.04, 149.06, 146.03, 145.98, 139.57, 139.34, 133.54, 
132.47, 132.37, 129.69, 128.99, 128.49, 124.24, 123.69, 121.79, 108.30, 105.24, 97.65, 67.87, 
44.42, 12.66. 19F NMR (282 MHz, chloroform-d) δ -128.72. HRMS (ESI) calculated for 
C33H34N4O2F ([M+H]+) 537.2666, found 537.2642 (∆ = -4.5 ppm). 
 
2,5-dioxopyrrolidin-1-yl-4-iodobutanoate (S3): To a flame-dried 100 mL round 
bottom flask was added 4-iodobutyric acid (100 mg, 0.467 mmol, 1.0 eq), N’-
ethylcarbodiimide hydrochloride (EDC-HCl) (450 mg, 2.34 mmol, 5.0 eq) N-
hydroxysuccinimide (270 mg, 2.34 mmol, 5.0 eq), and PTFE stir bar. The flask 
was cooled to 0 °C using an ice bath and 15 mL tetrahydrofuran was added. The reaction mixture 
was allowed to stir and warm to room temperature over the course of 0.5 h. The mixture was 
stirred for an additional 18 h, after which the solution was diluted with ethyl acetate (20 mL) and 
extracted with 10% w/v citric acid (20 mL). The organic layer was collected and washed with 10% 
w/v citric acid (2 x 30 mL) and saturated NaCl (2 x 20 mL), dried over MgSO4 and concentrated 
in vacuo to yield a brown oil. The oil was dissolved in a minimal amount of methylene chloride 
and loaded onto a Biotage SNAP Ultra cartridge for purification. Purification (6–50% ethyl 
acetate/hexanes over 15 CVs) afforded 101 mg (70%) of S3 as a pale yellow solid. This procedure 
was repeated as needed to generate more S3. 1H NMR (400 MHz, chloroform-d) δ 3.28 (t, J = 
6.7 Hz, 2H), 2.84 (s, 4H), 2.77 (t, J = 7.2 Hz, 2H), 2.24 (p, J = 6.9 Hz, 2H). 13C NMR (101 MHz, 
chloroform-d) δ 169.13, 167.69, 31.93, 28.25, 25.71, 4.01. HRMS (ESI) calculated for 
C8H10NO4INa ([M+Na]+) 333.9552, found 333.9546 (∆ = -1.8 ppm). 
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Rhodamine spirolactam (5): A flame-dried 2-neck (14/20) 25 mL 
round bottom flask was charged with rhodamine S2 (100 mg, 0.186 
mmol, 1.0 eq) and PTFE stir bar. Acetonitrile (10 mL) was added to 
the flask and methyl iodide (23.2 µL, 0.373 mmol, 2.0 eq) was 
subsequently added. The flask was quickly attached to a reflux 
condenser and refluxed at 92 °C for 3 h. TLC (2% v/v methanol in 
methylene chloride) was used to monitor the reaction and indicated the presence of starting 
material. Methyl iodide (23.2 µL, 0.373 mmol, 2.0 eq) was added to the refluxing solution after 2 
h. After an additional 1 h, TLC indicated the starting material had not been completely consumed. 
Another 2.0 eq of methyl iodide (23.2 µL, 0.373 mmol) was added to the solution. Over the next 
6 h, methyl iodide (23.2 µL, 0.373 mmol, 2.0 eq) was added every 2 h. After a total of 14 h, the 
amount of starting material did not decrease further, as indicated by TLC. The reaction mixture 
was cooled to room temperature and concentrated in vacuo. Flash chromatography (Biotage 
SNAP Ultra, 1–2% v/v methanol/methylene chloride over 15 CVs) afforded 88.4 mg (70%) of 
rhodamine spirolactam 5 as a brilliant red powder. 1H NMR (400 MHz, DMSO-d6) δ 9.36 (d, J = 
5.8 Hz, 1H), 8.72 (dd, J = 6.8, 1.5 Hz, 1H), 8.04 – 7.97 (m, 1H), 7.69 (td, J = 7.4, 1.4 Hz, 1H), 7.63 
(td, J = 7.4, 1.2 Hz, 1H), 7.13 (d, J = 7.5 Hz, 1H), 6.93 (t, J = 6.9 Hz, 1H), 6.60 (d, J = 8.9 Hz, 2H), 
6.44 (dd, J = 9.0, 2.6 Hz, 2H), 6.36 (d, J = 2.6 Hz, 2H), 4.16 (s, 3H), 3.34 – 3.22 (m, 8H), 1.08 (t, 
J = 6.9 Hz, 12H). 13C NMR (101 MHz, DMSO-d6) δ 165.89, 154.86, 154.24, 152.29, 152.08, 
151.95, 148.91, 143.86, 143.82, 139.93, 139.83, 137.38, 137.00, 135.25, 129.32, 128.02, 126.70, 
124.18, 123.71, 121.27, 108.79, 103.67, 97.13, 68.29, 48.03, 43.66, 12.38. 19F NMR (282 MHz, 
DMSO-d6) δ -118.19. HRMS (ESI) calculated for C34H36N4O2F ([M]+) 551.2822, found 551.2831 
(∆ = 1.6 ppm). 
 
Rhodamine spirolactam NHS ester (S4): A flame-dried 2-neck (14/20) 25 
mL round bottom flask was charged with rhodamine S1 (250 mg, 0.482 
mmol, 1.0 eq), NHS ester S3 (300 mg, 0.964 mmol, 2.0 eq), and PTFE 
stir bar. Acetonitrile (12 mL) was added and the flask was quickly 
attached to a reflux condenser. The solution was heated to 90 °C and 
allowed to stir under refluxing conditions for 48 h, after which the solution 
was cooled to room temperature and solvent was removed in vacuo, 
resulting in a tan precipitate. Ethyl acetate (10 mL) was added to the flask, 
and the solution was allowed to gently stir for 12 h, after which the solid 
was collected by filtration. The solid was washed with ethyl acetate (3 x 
10 mL) and dried under vacuum to afford 300 mg (75%) rhodamine 
spirolactam NHS ester S4 as a tan powder. 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 7.6 Hz, 
2H), 8.08 (d, J = 7.6 Hz, 2H), 8.03 – 8.01 (m, 1H), 7.67 (td, J = 7.5, 1.2 Hz, 1H), 7.59 (td, J = 7.4, 
1.0 Hz, 1H), 7.05 (d, J = 7.8 Hz, 1H), 6.57 (d, J = 8.9 Hz, 2H), 6.48 (d, J = 2.6 Hz, 2H), 6.31 (dd, 
J = 9.0, 2.6 Hz, 2H), 4.36 (t, J = 7.2 Hz, 2H), 3.33 – 3.22 (m, 8H), 2.80 (s, 4H), 2.79 – 2.74 (m, 
2H), 2.17 (q, J = 7.5 Hz, 2H), 1.07 (t, J = 7.0 Hz, 12H). 13C NMR (101 MHz, DMSO-d6) δ 170.15, 
169.13, 168.17, 154.07, 151.61, 149.87, 148.91, 144.85, 136.05, 129.23, 127.38, 125.47, 124.07, 
123.69, 115.09, 108.60, 103.98, 97.41, 66.85, 58.04, 43.63, 27.12, 25.45, 24.89, 12.39. HRMS 
(ESI) calculated for C41H44N5O6 ([M]+) 702.3292, found 702.3267 (∆ = -3.6 ppm). 
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Rhodamine spirolactam NHS ester S5: To a flame-dried 2-neck (14/20) 
50 mL round bottom flask was added rhodamine S2 (125 mg, 0.233 mmol, 
1.0 eq), NHS ester S3 (181.2 mg, 0.582 mmol, 2.5 eq), and PTFE stir bar. 
Acetonitrile (15 mL) was added to the flask and the flask was quickly 
attached to a reflux condenser. The solution was heated to 95 °C and 
allowed to reflux for 48 h, after which the solvent was removed in vacuo, 
resulting in a red oil with a purple hue. Ethyl acetate (5 mL) was added to 
the flask, and the solution was allowed to stir for 24 h at room temperature, 
resulting in a purple solid. The solid was collected by filtration, washed 
with ethyl acetate (3 x 5 mL), and dried under vacuum to afford 126 mg 
(64%) of rhodamine spirolactam NHS ester S5 as a purple powder. 1H NMR (400 MHz, DMSO-
d6) δ 9.41 (d, J = 5.8 Hz, 1H), 8.79 (d, J = 6.9 Hz, 1H), 8.04 – 8.00 (m, 1H), 7.69 (td, J = 7.5, 1.3 
Hz, 1H), 7.63 (td, J = 7.4, 1.1 Hz, 1H), 7.13 (d, J = 7.7 Hz, 1H), 6.99 (t, J = 6.9 Hz, 1H), 6.60 (d, 
J = 8.9 Hz, 2H), 6.44 (dd, J = 9.0, 2.6 Hz, 2H), 6.37 (d, J = 2.6 Hz, 2H), 4.48 (t, J = 7.1 Hz, 2H), 
3.33 – 3.25 (m, 8H), 2.81 (s, 4H), 2.80 – 2.77 (m, 2H), 2.23 (p, J = 7.4 Hz, 2H), 1.08 (t, J = 6.9 
Hz, 12H). 13C NMR (101 MHz, DMSO-d6) δ 170.14, 168.15, 165.90, 155.02, 154.27, 152.45, 
152.05, 148.91, 142.96, 140.41, 140.31, 136.67, 136.29, 135.32, 129.31, 127.96, 126.54, 124.16, 
123.75, 121.12, 108.81, 103.78, 97.16, 68.38, 43.65, 40.15, 39.94, 39.73, 39.52, 39.31, 39.10, 
38.89, 27.07, 25.45, 24.65, 12.37. HRMS (ESI) calculated for C41H43N5O6F ([M]+) 720.3197, found 
720.3178 (∆ = -2.6 ppm). 
 
Bicyclononyne rhodamine conjugate (2): To a 20 
mL scintillation vial was added ester S4 (15 mg, 
18.1 µmol, 1.0 eq), 0.5 mL dimethylformamide, and 
a PTFE stir bar. BCN-NH2 (see Scheme S3) (7.62 
mg, 23.5 µmol, 1.3 eq, dissolved in 1.0 mL 
dimethylformamide) was added to the solution; 
N,N-diisopropylethylamine (5.6 µL, 32.01 µmol, 1.8 
eq) was added subsequently. The reaction mixture 
was allowed to stir for 2 h at room temperature, after 
which the crude mixture was directly dry loaded 
onto Celite. Flash chromatography (Biotage SNAP 
KP-NH, 0–20% methanol/ethyl acetate over 15 
CVs) afforded 11.1 mg (59%) of 2 as a pale yellow film. 1H NMR (400 MHz, chloroform-d) δ 8.70 
(d, J = 7.0 Hz, 2H), 8.25 (d, J = 7.3 Hz, 2H), 8.01 – 7.98 (m, 1H), 7.57 (td, J = 7.5, 1.2 Hz, 1H), 
7.49 (td, J = 7.5, 1.0 Hz, 1H), 7.08 – 7.06 (m, 1H), 6.46 (d, J = 2.6 Hz, 2H), 6.43 (d, J = 8.9 Hz, 
2H), 6.22 (dd, J = 9.0, 2.6 Hz, 2H), 5.47 (br s, 1H), 4.75 (t, J = 7.8 Hz, 2H), 4.17 – 4.07 (m, 3H), 
3.62 – 3.59 (m, 4H), 3.58 – 3.53 (m, 3H), 3.54 – 3.48 (m, 2H), 3.39 – 3.29 (m, 12H), 2.51 (t, J = 
6.8 Hz, 2H), 2.26 – 2.20 (m, 7H), 1.64 – 1.52 (m, 3H), 1.38 – 1.31 (m, 1H), 1.17 (t, J = 7.1 Hz, 
12H), 0.92 (t, J = 10.0 Hz, 2H). 13C NMR (101 MHz, chloroform-d) δ 171.85, 171.74, 170.12, 
157.06, 154.46, 152.49, 152.15, 151.11, 149.66, 143.70, 136.07, 129.08, 127.02, 125.71, 124.42, 
124.06, 115.93, 108.77, 108.07, 103.77, 99.00, 98.38, 98.00, 70.41, 70.33, 70.26, 69.59, 68.05, 
62.75, 60.55, 58.90, 44.53, 40.85, 40.73, 39.29, 39.16, 32.35, 29.21, 28.10, 21.59, 21.21, 20.23, 
17.94, 14.34, 12.74. HRMS (ESI) calculated for C54H67N6O7 ([M]+) 911.5071, found 911.5060 (∆ 
= -1.2 ppm). 
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Bicyclononyne rhodamine conjugate (3): To a 20 
mL scintillation vial was added ester S5 (12 mg, 
14.2 µmol, 1.0 eq), 0.5 mL dimethylformamide, and 
a PTFE stir bar. BCN-NH2 (see Scheme S3) (9.19 
mg, 28.3 µmol, 2.0 eq, dissolved in 1.0 mL 
dimethylformamide) was added to the solution; 
N,N-diisopropylethylamine (3.71 µL, 21.3 µmol, 1.5 
eq) was added subsequently. The reaction mixture 
was allowed to stir for 2 h at room temperature, after 
which the crude mixture was directly dry loaded 
onto Celite. Flash chromatography (Biotage SNAP 
KP-NH, 0–20% methanol/ethyl acetate over 15 
CVs) afforded 1.4 mg (9.6%) of 3 as a purple film. 1H NMR (400 MHz, chloroform-d) δ 9.02 – 8.97 
(m, 1H), 8.02 (d, J = 7.4 Hz, 1H), 7.65 – 7.46 (m, 3H), 7.14 – 7.08 (m, 1H), 6.58 (d, J = 8.9 Hz, 
2H), 6.36 (d, J = 2.5 Hz, 2H), 6.31 (dd, J = 9.1, 2.7 Hz, 2H), 6.23 – 6.20 (m, 1H), 5.45 (s, 1H), 
4.96 (s, 1H), 4.21 – 4.07 (m, 3H), 3.69 – 3.53 (m, 9H), 3.43 – 3.29 (m, 12H), 2.55 – 2.41 (m, 2H), 
2.34 – 2.15 (m, 7H), 1.41 – 1.30 (m, 4H), 1.18 (t, J = 7.1 Hz, 12H), 1.00 – 0.90 (m, 2H). 13C NMR 
(101 MHz, chloroform-d) δ 173.03, 168.44, 166.70, 157.12, 156.37, 154.54, 153.14, 152.71, 
149.67, 144.47, 136.75, 135.20, 134.68, 128.00, 124.41, 124.35, 108.99, 108.27, 108.10, 103.89, 
101.60, 99.00, 97.94, 70.41, 70.36, 70.24, 69.62, 68.10, 62.82, 60.56, 57.62, 44.55, 40.90, 40.84, 
39.37, 39.10, 31.98, 29.20, 27.95, 21.59, 21.22, 20.25, 17.93, 14.35, 12.75. 19F NMR (376 MHz, 
chloroform-d) δ -111.36. HRMS (ESI) calculated for C54H66N6O7F ([M]+) 929.4977, found 
929.4978 (∆ = 0.1 ppm). 
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Figure S1: Absorption spectra of rhodamine 4 in bis-tris propane at different pH values. (A) 
Structure of 4. (B) Absorbance at 561 nm as a function of pH. (C) Absorption spectra of 4 across 
different pH ranges. Error bars denote the standard deviation from three independent experiments.   
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Figure S2: Fluorescence emission from rhodamine 4 in bis-tris propane at different pH values. 
(A) Structure of 4. (B) Fluorescence emission at 577 nm as a function of pH. (C) Fluorescence 
emission spectra of 4 across different pH ranges. Error bars denote the standard deviation from 
three independent experiments. 
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Figure S3: Absorption spectra of rhodamine 5 in bis-tris propane at different pH values. (A) 
Structure of 5. (B) Absorption spectra at 563 nm as a function of pH. (C) Absorption spectra of 5 
across different pH ranges. Error bars denote the standard deviation from three independent 
experiments.   
A B
C
Ab
so
rb
an
ce
 (a
.u
.)
pH
Wavelength (nm)
Ab
so
rb
an
ce
 (a
.u
.)
5
H3C N
N
O
N
N
O
I
F
Supporting Information  Ho and Tirrell 
 – 11 – 
 
 
Figure S4: Fluorescence emission from rhodamine 5 in bis-tris propane at different pH values. 
(A) Structure of 5. (B) Fluorescence emission at 578 nm as a function of pH. (C) Fluorescence 
emission spectra of 5 across different pH ranges. Error bars denote the standard deviation from 
three independent experiments.  
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Figure S5: Spectroscopic characterization of rhodamine 4 in different solvents. (A) Structure of 
4. (B) Absorption spectra of 4 in different solvents. (C) Absorption and fluorescence emission 
spectra of 4. Absorption spectrum was taken in 1:1 water: acetonitrile (solid blue line) or 1:1 water: 
acetonitrile with addition of 1 M HCl (dashed blue line). Emission spectrum was taken in acidic 
ethanol (orange line). 
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Figure S6: Spectroscopic characterization of rhodamine 5 in different solvents. (A) Structure of 
5. (B) Absorption spectra of 5 in different solvents. (C) Absorption and fluorescence emission 
spectra of 5. Absorption spectrum was taken in 1:1 water: acetonitrile (solid blue line) or 1:1 water: 
acetonitrile with addition of 1 M HCl (dashed blue line). Emission spectrum was taken in acidic 
ethanol (orange line). 
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Figure S7: Spectroscopic characterization of rhodamines 4 and 5 in solvents of different dielectric 
constants. Rhodamines were dissolved in mixtures of dioxane and water and absorbance and 
fluorescence emission were measured as a function of dielectric constant. (A) Absorbance at 561 
nm for 4. (B) Fluorescence emission at 577 nm for 4. (C) Absorbance at 563 nm for 5. (D) 
Fluorescence emission at 578 nm for 5. Error bars represent the standard deviation from three 
independent experiments. a.u. = arbitrary units; cps = counts per second.  
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Figure S8: Radial and axial resolutions for E. coli cells expressing Tar and labeled with 2. 
Precision was calculated with 50 clusters that had ≥5 localizations. Histogram for the X-resolution 
gave a deviation of 12 nm in the x direction (gray dashed line represents Gaussian fit) and a 
FWHM of 28 nm. Histogram for the Y-resolution gave a deviation of 15 nm in the y direction (gray 
dashed line represents Gaussian fit) and a FWHM of 35 nm. Histogram for the Z-resolution gave 
a deviation of 27 nm in the z direction (gray dashed line represents Gaussian fit) and a FWHM of 
64 nm.   
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Figure S9: Super-resolution imaging of bacterial proteins in live cells labeled with 3. Cells 
expressing one of four bacterial proteins were labeled with 1 and 3. (A) STORM images of 
bacterial proteins with polar localization (Tar and CheA) or septal localization (FtsZ and FtsA) 
expressed in E. coli. Brightfield images of cells are shown in the top left corner of fluorescence 
images. (B) Histogram indicating number of detected photons during image acquisition with fit to 
single exponential. The mean number of photons was calculated from the exponential fit (blue 
curve). (C) Mean radial precision for imaging in live bacterial cells.  
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Figure S10: Radial and axial resolutions for E. coli cells expressing Tar and labeled with 3. 
Precision was calculated with 50 clusters that had ≥5 localizations. Histogram for the X-resolution 
gave a deviation of 12 nm in the x direction (gray dashed line represents Gaussian fit) and a 
FWHM of 28 nm. Histogram for the Y-resolution gave a deviation of 18 nm in the y direction (gray 
dashed line represents Gaussian fit) and a FWHM of 42 nm. Histogram for the Z-resolution gave 
a deviation of 21 nm in the z direction (gray dashed line represents Gaussian fit) and a FWHM of 
49 nm.   
  
Nu
m
be
r o
f p
oin
ts σz: 21 nm
z (nm)
Nu
m
be
r o
f p
oin
ts σy: 18 nm
y (nm)
Nu
m
be
r o
f p
oin
ts σx: 12 nm
x (nm)
Supporting Information  Ho and Tirrell 
 – 18 – 
 
 
Figure S11: Control imaging experiments with live cells labeled with 2. (A) Cells that did not 
express the protein of interest (Tar), labeled only with 2 (no added 1). (B) Cells that did not 
express the protein of interest (Tar), treated with 1 and 2. (C) Cells that expressed Tar labeled 
only with 2 (no added 1).  None of these controls shows any distinct localization pattern. For all 
images, brightfield images of cells are shown in the top left corner of the fluorescence image. 
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Figure S12: Control imaging experiments with live cells labeled with 3. (A) Cells that do not 
express the protein of interest (Tar) and not been treated with 1 but labeled with 3 show no distinct 
localization patterns. (B) Cells that do not express the protein of interest (Tar) but have been 
treated with 1 and 3 show no distinct localization patterns. (C) Cells that express Tar but are not 
treated with 1 and are labeled with 3 show no distinct localization patterns. For all images, 
brightfield images of cells are shown in the top left corner of the fluorescence image. 
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Figure S13: Addition of dyes 2 or 3 does not affect cell growth. Cells were diluted from an 
overnight culture to an OD600 = 0.01 in LB. Cells were then treated with either (A) 2 or (B) 3 and 
continued to grow through the course of 14 h. OD600 was monitored every 10 min for each culture. 
E. coli strain SHH009 (strain bearing plasmids pBAD24-hCaNB-Tar-cmyc and pHV738-NMT-
MetAP) was used in this experiment. Error bars represent the standard deviation from three 
independent experiments. 
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Figure S14: Growth effects of protein expression, the N-terminal NMT recognition sequence, and 
modification with fatty acid. Overnight cultures of cells bearing pBAD24 plasmids encoding inducible 
expression of Tar (A–C) or FtsA (D–F) and constitutive expression of NMT were diluted to OD600 = 0.1 in 
LB medium (20 mL culture in 125 mL flasks) and grown until OD600 = 0.5. (B, E): At OD600 = 0.5, induction 
was performed by addition of 0.2% w/v arabinose; no 1 was added. (C, F): Induction and N-terminal labeling 
(by addition of 0.2% w/v arabinose, 250 µM 1) was initiated at OD600 = 0.5. (A, D): Uninduced cells. For all 
cultures, OD600 was measured every 20 min. Error bars denote the standard deviation from three 
independent experiments. (G): Summary of strains generated.   
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Figure S15: 1H NMR spectrum of compound S1. * = chloroform. 
 
 
Figure S16: 13C NMR spectrum of compound S1. * = chloroform. 
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Figure S17: 1H NMR spectrum of compound S3. * = chloroform. 
 
 
 
Figure S18: 13C NMR spectrum of compound S3. * = chloroform.  
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Figure S19: 1H NMR spectrum of compound 4. *** = dimethyl sulfoxide; **** = water.  
 
Figure S20: 13C NMR spectrum of compound 4. *** = dimethyl sulfoxide.  
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Figure S21: 1H NMR spectrum of compound S4. ** = ethyl acetate; *** = dimethyl sulfoxide; **** = water. 
 
Figure S22: 13C NMR spectrum of compound S4. ** = ethyl acetate; *** = dimethyl sulfoxide. 
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Figure S23: 1H NMR spectrum of compound 2. * = chloroform; ** = ethyl acetate; **** = water. 
 
Figure S24: 13C NMR spectrum of compound 2. * = chloroform. 
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Figure S25: 1H NMR spectrum of compound S2. * = chloroform; ** = ethyl acetate. 
 
Figure S26: 13C NMR spectrum of compound S2. * = chloroform; ** = ethyl acetate. 
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Figure S27: 19F NMR spectrum of compound S2. 
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Figure S28: 1H NMR spectrum of compound 5. ** = ethyl acetate; *** = dimethyl sulfoxide; **** = 
water. 
 
Figure S29: 13C NMR spectrum of compound 5. ** = ethyl acetate; *** = dimethyl sulfoxide.  
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Figure S30: 19F NMR spectrum of compound 5. 
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Figure S31: 1H NMR spectrum of compound S5. ** = ethyl acetate; *** = dimethyl sulfoxide; **** 
= water. 
 
Figure S32: 13C NMR spectrum of compound S5. ** = ethyl acetate; *** = dimethyl sulfoxide. 
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Figure S33: 19F NMR spectrum of compound S5. 
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Figure S34: 1H NMR spectrum of compound 3. * = chloroform; **** = water. 
 
 
Figure S35: 13C NMR spectrum of compound 3. * = chloroform.  
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Figure S36: 19F NMR spectrum of compound 3. 
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Figure S37: LC-MS trace of 2 (0–95% MeCN in water buffered with 0.1% v/v acetic acid). 
 
 
 
 
Figure S38: High-resolution mass spectrum of 2. 
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Figure S39: LC-MS trace of 3 (0–95% MeCN in water buffered with 0.1% v/v acetic acid). 
 
 
 
 
Figure S40: High-resolution mass spectrum of 3. 
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